BioVie Inc (BIVI)
3.05
-0.06
(-1.93%)
USD |
NASDAQ |
Nov 22, 16:00
3.11
+0.06
(+1.97%)
After-Hours: 20:00
BioVie Free Cash Flow: -19.35M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -19.35M |
| June 30, 2024 | -27.94M |
| March 31, 2024 | -35.23M |
| December 31, 2023 | -41.11M |
| September 30, 2023 | -43.21M |
| June 30, 2023 | -40.25M |
| March 31, 2023 | -34.83M |
| December 31, 2022 | -28.98M |
| September 30, 2022 | -25.68M |
| June 30, 2022 | -18.99M |
| March 31, 2022 | -20.13M |
| December 31, 2021 | -15.29M |
| September 30, 2021 | -11.90M |
| June 30, 2021 | -10.45M |
| March 31, 2021 | -3.805M |
| December 31, 2020 | -3.165M |
| September 30, 2020 | -2.121M |
| June 30, 2020 | -1.628M |
| March 31, 2020 | -1.900M |
| December 31, 2019 | -2.157M |
| September 30, 2019 | -2.651M |
| Date | Value |
|---|---|
| June 30, 2019 | -2.502M |
| March 31, 2019 | -2.079M |
| December 31, 2018 | -1.469M |
| September 30, 2018 | -0.8598M |
| June 30, 2018 | -0.6213M |
| March 31, 2018 | -0.5372M |
| December 31, 2017 | -0.7572M |
| September 30, 2017 | -0.699M |
| June 30, 2017 | -0.6236M |
| March 31, 2017 | -0.6178M |
| December 31, 2016 | -0.3654M |
| September 30, 2016 | -0.2797M |
| June 30, 2016 | -0.1536M |
| March 31, 2016 | -0.0453M |
| December 31, 2015 | -0.0385M |
| September 30, 2015 | -0.0526M |
| June 30, 2015 | -0.0654M |
| March 31, 2015 | -0.0667M |
| December 31, 2014 | -0.1188M |
| September 30, 2014 | -0.1277M |
| June 30, 2014 | -0.1728M |
Free Cash Flow Range, Past 5 Years
-43.21M
Minimum
Sep 2023
-1.628M
Maximum
Jun 2020
-19.41M
Average
-19.17M
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 221.79M |
| MediciNova Inc | -8.553M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.580M |
| Cash from Financing (Quarterly) | -0.2409M |
| Free Cash Flow Per Share (Quarterly) | -0.5594 |
| Free Cash Flow Yield | -121.9% |